Form 4 for SKYE Skye Bioscience, Inc.
Accepted 2023-03-17 00:00:00 ET · period of report 2022-11-10 · accession 0001567619-23-005234 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-17 | 2023-02-22 | SKYE | Emerald Health Sciences Inc. | 10% | A - Grant | $0.0343 | +58.02M | 169.41M | +52% | +$1.99M |
| D | 2023-03-17 | 2023-02-22 | SKYE | Emerald Health Sciences Inc. | 10% | P - Purchase | $0.00 | -2.50M | 0 | -100% | $0 |
| DM | 2023-03-17 | 2023-02-22 | SKYE | Emerald Health Sciences Inc. | 10% | D - Sale to Iss | $0.00 | -14.14M | 0 | -100% | $0 |
| D | 2023-03-17 | 2022-11-10 | SKYE | Emerald Health Sciences Inc. | 10% | J - Other | $0.00 | +9.14M | 9.14M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | A | A | 16,641,486 | $0.02 | 128,028,737 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-22 | A | A | 41,379,164 | $0.04 | 169,407,901 | D | — | — | |
| 3 | Derivative | Warrants with Credit Facility of Oct 5, 2018 | 2023-02-22 | P | D | 2,500,000 | $0.00 | 0 | D | $0.04 · 2018-11-01 to 2023-11-01 | 2,500,000 Common Stock | |
| 4 | Derivative | Warrants with Credit Facility of Oct 5, 2018 - T3 | 2023-02-22 | D | D | 2,500,000 | $0.00 | 0 | D | $0.04 · 2019-03-29 to 2024-03-29 | 2,500,000 Common Stock | |
| 5 | Derivative | Warrants | 2023-02-22 | D | D | 9,141,486 | $0.00 | 0 | D | $0.02 · 2023-11-10 to 2024-12-30 | 9,141,486 Common Stock | |
| 6 | Derivative | Warrants | 2022-11-10 | J | A | 9,141,486 | $0.00 | 9,141,486 | D | $0.15 · 2023-11-10 to 2024-12-30 | 9,141,486 Common Stock | |
| 7 | Derivative | Warrants with Credit Facility of Oct 5, 2018 - T2 | 2023-02-22 | D | D | 2,500,000 | $0.00 | 0 | D | $0.04 · 2019-02-01 to 2024-02-01 | 2,500,000 Common Stock |